Search the Newsreel

IQVIA (NYSE:IQV): Quality Stock Surges on Q2 Earnings Beat and Raised Outlook

IQVIA (NYSE:IQV) reported a strong second-quarter performance, exceeding profit expectations and raising its full-year outlook, which sent shares higher in pre-market trading. The company achieved record net new bookings and substantial growth in both its Commercial Solutions and Research & Development Solutions segments. Management …

IQVIA’s (NYSE:IQV) Q2 CY2026 Sales Top Estimates, Stock Soars

IQVIA's (NYSE:IQV) Q2 CY2026 Sales Top Estimates, Stock Soars Clinical research company IQVIA (NYSE: IQV) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 8.7% year on year to $4.37 billion. The company's full-year revenue guidance of $17.38 billion at the midpoint …

IQVIA Holdings Inc. (IQV) Stock Price Today

This article provides current stock information for IQVIA Holdings Inc. (IQV), including its live price, key market data, and recent performance trends. It also offers a detailed company overview, instructions on how to purchase IQV stock on MEXC, and answers to frequently asked questions …

IQVIA: Q2 Earnings Snapshot

This article provides a brief earnings snapshot for IQVIA's Q2 results. However, the provided content is extremely limited and does not contain any specific financial details or further information beyond the title.

Earnings Flash (IQV) IQVIA Holdings Inc. Posts Q2 Adjusted EPS $3.15 per Share, vs. FactSet Est of $3.03

IQVIA Holdings Inc. (IQV) reported its Q2 adjusted EPS of $3.15 per share, surpassing the FactSet estimate of $3.03. This earnings flash was published on July 28, 2026, at 07:19 am EDT, indicating a stronger-than-expected financial performance for the quarter.

Earnings Flash (IQV) IQVIA Holdings Inc. Reports Q2 Revenue $4.37B, vs. FactSet Est of $4.30B

IQVIA Holdings Inc. reported Q2 revenue of $4.37 billion, surpassing FactSet's estimate of $4.30 billion. The company also announced Q2 adjusted EPS of $3.15 per share, exceeding the FactSet estimate of $3.03, and raised its 2026 revenue outlook to $17.28B - $17.48B.

IQVIA Holdings earnings beat by $0.11, revenue topped estimates

IQVIA Holdings (NYSE: IQV) reported better-than-expected Q2 earnings and revenue, with EPS of $3.15 against an analyst estimate of $3.04, and revenue of $4.37 billion exceeding the consensus of $4.3 billion. The company also issued a strong full-year 2026 guidance, forecasting EPS between $12.80 …

IQVIA reports Q2 2026 revenue $4,368M, adjusted EPS $3.15 and raises full-year guidance

IQVIA reported strong financial results for Q2 2026, with revenue of $4,368 million and adjusted diluted EPS of $3.15, marking significant year-over-year growth. The company raised its full-year guidance for revenue, adjusted EBITDA, and adjusted diluted EPS, driven by record R&D Solutions bookings and …

IQVIA Non-GAAP EPS of $3.15 beats by $0.12, revenue of $4.37B beats by $70M

* IQVIA press release [https://seekingalpha.com/pr/20597017-iqvia-reports-second-quarter-2026-results] (IQV [https://seekingalpha.com/symbol/IQV]): Q2 Non-GAAP EPS of $3.15 beats by $0.12. * Revenue of $4.37B (+8.7% Y/Y) beats by $70M. * Commercial Solutions Revenue $1,793 million, up 8.6% year-over-year * R&D Solutions Revenue $2,575 million, up 8.8% year-over-year * R&D …

IQVIA Holdings (NYSE: IQV) grows Q2 revenue to $4.37B and raises 2026 outlook

IQVIA Holdings reported strong Q2 2026 results, with revenue growing 8.7% to $4.37 billion and Adjusted Diluted EPS increasing by 12.1% to $3.15. The company also raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted Diluted EPS due to stronger organic growth …

IQVIA earnings up next: Can AI expand CRO demand or squeeze margins?

IQVIA Holdings Inc. is set to report its Q2 earnings, with investors focused on how artificial intelligence will impact the contract research organization's business, specifically whether AI will expand demand or compress margins. Analysts expect EPS of $3.03 and revenue of $4.3 billion, showing …

Earnings To Watch: IQVIA (IQV) Reports Q2 Results Tomorrow

IQVIA (IQV) is set to report its Q2 earnings tomorrow before market hours. The clinical research company beat revenue expectations last quarter and analysts anticipate 7.1% year-on-year revenue growth this quarter. Peers like Medpace and West Pharmaceutical Services have already reported Q2 results, offering …

IQVIA Holdings stock trades near record territory as data-driven growth supports valuation

IQVIA Holdings' stock is trading near record levels, supported by its strong performance in healthcare data analytics and clinical services. The company has shown double-digit revenue growth across its segments, driven by demand for real-world evidence and technology-enabled services, leading to improved profitability and …

IQV Earning Date, Earning Analysis and Earning Prediction

This article provides an earnings analysis and prediction for IQV, including key dates, revenue and EPS estimates from analysts and AI, and historical stock reactions to earnings reports. It highlights that analysts project IQV's Q2 2026 revenue at $4.23B and EPS at $3.04, with …

IQVIA Holdings Inc (IQV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for IQVIA Holdings Inc (IQV), detailing its financial performance by geographical region. As of the latest available data, the Americas contribute 47.49% of the revenue, followed by Europe & Africa at 31.79%, and the Asia Pacific region at …

IQVIA Gears Up to Report Q2 Earnings: What's in the Offing?

IQVIA Holdings Inc. (IQV) is scheduled to release its second-quarter 2026 earnings on July 28, with expectations of significant revenue and EPS growth driven by AI integration and strong performance in commercial and R&D solutions. Despite a strong earnings surprise history, the company's current …

IQV|IQVIA Holdings Inc|Price:209.370|Chg%:+2.050

This article provides a detailed financial overview of IQVIA Holdings Inc. (IQV), including its stock price, market capitalization, P/E ratio, and upcoming earnings date. It presents comprehensive financial data through income statements, balance sheets, and cash flow statements, highlighting quarterly and annual performance metrics …

IQVIA stock trades steadily as data and technology demand supports growth

IQVIA Holdings, a major global provider of advanced analytics, technology solutions, and clinical research services, shows steady growth. Recent financial results indicate increasing revenue and earnings, driven by strong demand for data-driven decision support in pharmaceuticals and healthcare across its Technology & Analytics Solutions, …

IQV: IQVIA Holdings Inc Latest Stock Price, Analysis, News and Trading Ideas

This page provides real-time stock information for IQVIA Holdings Inc (IQV), including its current price, market capitalization, volume, and key financial ratios. It also features recent news articles related to IQV's earnings and company developments, alongside trending discussions on other stocks like HIMS, NOW, …

IQVIA BDR program executes 4-for-1 stock split in Brazil on Aug. 26

IQVIA will implement a mandatory BDR stock split in Brazil on August 26, 2026, changing the ratio from 1:4 to 1:16. Holders will receive three additional BDRs for every one held, with the ex-date set for August 24, 2026, and new BDRs credited on …

IQVIA Holdings stock holds its ground as investors await fresh data

IQVIA Holdings' stock is holding steady, anchored by its strong position in clinical research, data, and analytics. The company reported $15.4 billion in annual revenue, $1.3 billion in net income, and a significant $24.4 billion backlog, indicating strong future revenue visibility. These figures highlight …

IQVIA Holdings stock trades steady as data-driven growth supports recent earnings

IQVIA Holdings stock is trading steadily, supported by strong revenue growth and solid margin trends from its diversified portfolio of contract research, real-world data, and technology services. The company's financial reporting for fiscal 2024 showed mid-single-digit revenue growth and high-single-digit earnings expansion, driven significantly …

IQVIA Holdings (IQV) Q1 2024 Earnings Report - Results, Call & Slides

IQVIA Holdings (IQV) released its Q1 2024 earnings report, achieving an actual EPS of $2.54, surpassing the consensus of $2.49. The company also reported actual revenue of $3.74 billion, beating the expected $3.70 billion, with a year-over-year revenue growth of 2.89%. The earnings call …

IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth

The market expects IQVIA Holdings (IQV) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might …

IQVIA Holdings Inc. stock underperforms Monday when compared to competitors

IQVIA Holdings Inc. (IQV) shares fell by 1.14% to $203.90 on Monday, marking its second consecutive day of losses. This underperformance occurred during a broader market decline, with the S&P 500 Index (SPX) falling 0.19% and the Dow Jones Industrial Average (DJIA) falling 0.59%.

IQVIA Holdings stock trades steadily as data-driven healthcare growth supports valuation

IQVIA Holdings (NYSE: IQV) shows steady stock performance, driven by strong demand for its data-driven healthcare services from biopharmaceutical clients. The company reported mid-single-digit revenue growth and sustained profitability in its latest fiscal year, with recurring revenue from technology and analytics platforms supporting its …

(IQV) Price Dynamics and Execution-Aware Positioning

This article provides an in-depth analysis of Iqvia Holdings Inc. (NYSE: IQV) focusing on its price dynamics and execution-aware positioning. Key findings indicate a neutral near-term outlook with a potential stall in mid-term strong sentiment, highlighted by a significant risk-reward short setup. The analysis …

IQVIA (IQV) Goes To Congress Over Early Clinical Development Rules

IQVIA (IQV) executive Dr. Cynthia Verst testified before a U.S. House subcommittee on modernizing early clinical development, highlighting the company's role in shaping regulatory and research infrastructure. This engagement positions IQVIA as an active voice in policy conversations, which could influence future clinical standards …

IQVIA Holdings Inc. stock outperforms competitors despite losses on the day

IQVIA Holdings Inc. stock dropped 2.01% on Friday, underperforming the broader market as the S&P 500 fell 1.01% and the Dow Jones Industrial Average dropped 0.77%. Despite the daily loss, the company's shares are still outperforming some competitors, though they remain 16.51% below their …

IQVIA Holdings stock trades steadily as data-driven growth supports valuations

IQVIA Holdings stock maintains steady trading, driven by consistent revenue growth, expanding margins, and strategic investments in AI-powered healthcare analytics. The company's financials for fiscal year 2023 reflect strong demand for its technology-enabled services, contributing to a robust market valuation. With a focus on …

Form 4 IQVIA Holdings Inc For: 16 July By Investing.com

This article from Investing.com announces the filing of a Form 4 for IQVIA Holdings Inc. on July 16. It is a brief, stock market-related news piece with minimal additional content, primarily serving as a notification of the regulatory filing. The article indicates the publication …

IQVIA Holdings (NYSE: IQV) grants director 148 deferred shares

IQVIA Holdings director Wims Morris Leslie was granted 148 deferred shares on July 14, 2026, with a reference value of $207.83 per share. These deferred shares convert into common stock upon settlement events like the director ceasing service, a change in control, or death, …

IQVIA Seeks Faster Path From Discovery to Human Drug Trials

IQVIA's Dr. Cynthia Verst testified before a U.S. House subcommittee, advocating for a more efficient and defined path from scientific discovery to early clinical development in the United States. She outlined recommendations, including establishing fit-for-first-in-human minimum datasets and expanding access to timely scientific advice, …

IQVIA Holdings Inc. (NYSE:IQV) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

IQVIA’s (NYSE:IQV) Q4 CY2025 Sales Top Estimates

IQVIA Holdings Inc.'s (NYSE:IQV) P/E Still Appears To Be Reasonable